UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.320

Sortiert nach

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Journal of antimicrobial chemotherapy, 1999, Vol.43 (1), p.79-86

1999

Volltextzugriff (PDF)

Pharmacodynamics of Trovafloxacin, Ofloxacin, and Ciprofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model

Antimicrobial Agents and Chemotherapy, 1999-05, Vol.43 (5), p.1118-1123

1999

Volltextzugriff (PDF)

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae

Journal of antimicrobial chemotherapy, 2001-06, Vol.47 (6), p.811-818

2001

Volltextzugriff (PDF)

Pharmacodynamics of Moxifloxacin and Levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacodynamic Model

Clinical infectious diseases, 2001-03, Vol.32 (Supplement-1), p.S33-S38

Lister, P D

2001

Volltextzugriff (PDF)

Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin

Antimicrobial Agents and Chemotherapy, 1999-04, Vol.43 (4), p.882-889

1999

Volltextzugriff (PDF)

β-Lactamase Inhibitor Combinations with Extended-Spectrum Penicillins: Factors Influencing Antibacterial Activity against Enterobacteriaceae and Pseudomonas aeruginosa

Pharmacotherapy, 2000-09, Vol.20 (9P2), p.213S-218S

Lister, Philip D.

2000

Volltextzugriff (PDF)

Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies

Antimicrobial Agents and Chemotherapy, 1997-09, Vol.41 (9), p.1926-1932

1997

Volltextzugriff (PDF)

Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance

FEMS microbiology letters, 2004-07, Vol.236 (1), p.137-143

2004

Volltextzugriff (PDF)

Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam

Antimicrobial Agents and Chemotherapy, 1997-04, Vol.41 (4), p.721-727

1997

Volltextzugriff (PDF)

Pharmacodynamics of Gatifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model: Impact of Area under the Curve/MIC Ratios on Eradication

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.69-74

LISTER, Philip D

2002

Volltextzugriff (PDF)

Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections

European journal of clinical microbiology & infectious diseases, 1995, Vol.14 Suppl 1, p.S18

Lister, P D

1995

Volltextzugriff (PDF)

Levofloxacin-Imipenem Combination Prevents the Emergence of Resistance among Clinical Isolates of Pseudomonas aeruginosa

Clinical infectious diseases, 2005-02, Vol.40 (Supplement-2), p.S105-S114

2005

Volltextzugriff (PDF)

Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1610-1619

1998

Volltextzugriff (PDF)

Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions

Antimicrobial Agents and Chemotherapy, 1996-11, Vol.40 (11), p.2468-2477

1996

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia

The Journal of infectious diseases, 1993-10, Vol.168 (4), p.922

1993

Volltextzugriff (PDF)

Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones

Journal of antimicrobial chemotherapy, 2003-01, Vol.51 (1), p.199-202

Lister, Philip D

2003

Volltextzugriff (PDF)

Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice

Antimicrobial Agents and Chemotherapy, 1995-04, Vol.39 (4), p.930-936

1995

Volltextzugriff (PDF)

Preface

Journal of antimicrobial chemotherapy, 2013-05, Vol.68 (suppl 1), p.i1-i1

2013

Volltextzugriff (PDF)

Effect of drug treatment options on the mobility and expression of blaKPC

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2779-2785

2013

Volltextzugriff (PDF)

Emerging resistance problems among respiratory tract pathogens

The American journal of managed care, 2000-05, Vol.6 (8 Suppl), p.S409-S418

Lister, P D

2000

Volltextzugriff (PDF)

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype

Journal of antimicrobial chemotherapy, 2009-08, Vol.64 (2), p.294-300

2009

Volltextzugriff (PDF)

In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations

Antimicrobial Agents and Chemotherapy, 1990-01, Vol.34 (1), p.159-160

1990

Volltextzugriff (PDF)

The role of pharmacodynamic research in the assessment and development of new antibacterial drugs

Biochemical pharmacology, 2006-03, Vol.71 (7), p.1057-1065

Lister, Philip D.

2006

Volltextzugriff (PDF)

Ethanol impairs neutrophil chemotaxis in vitro but not adherence or recruitment to lungs of rats with experimental pneumococcal pneumonia

The Journal of infectious diseases, 1993-05, Vol.167 (5), p.1131

1993

Volltextzugriff (PDF)

Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae

Diagnostic microbiology and infectious disease, 2002-09, Vol.44 (1), p.43-49

Lister, Philip D

2002

Volltextzugriff (PDF)

1 – 25 von 1.320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(981)
Mit Volltextzugriff
(1.255)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(626)
Physical Sciences
(374)
Physics
(266)
Life Sciences & Biomedicine
(229)
Humans
(159)
Nuclear Physics And Radiation Physics
(128)
Physics, Nuclear
(127)
Biological And Medical Sciences
(126)
Exact Sciences And Technology
(123)
Astronomy & Astrophysics
(108)
Medical Sciences
(105)
Male
(91)
Female
(76)
Technology
(72)
Earth, Ocean, Space
(67)
Animals
(62)
Adult
(61)
Middle Aged
(61)
Astronomy
(53)
Nuclei
(52)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Pharmacodynamics of Trovafloxacin, Ofloxacin, and Ciprofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae

Pharmacodynamics of Moxifloxacin and Levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacodynamic Model

Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin

β-Lactamase Inhibitor Combinations with Extended-Spectrum Penicillins: Factors Influencing Antibacterial Activity against Enterobacteriaceae and Pseudomonas aeruginosa

Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies

Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance

Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam

Pharmacodynamics of Gatifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model: Impact of Area under the Curve/MIC Ratios on Eradication

Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections

Levofloxacin-Imipenem Combination Prevents the Emergence of Resistance among Clinical Isolates of Pseudomonas aeruginosa

Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa

Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions

Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia

Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones

Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice

Preface

Effect of drug treatment options on the mobility and expression of blaKPC

Emerging resistance problems among respiratory tract pathogens

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype

In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations

The role of pharmacodynamic research in the assessment and development of new antibacterial drugs

Ethanol impairs neutrophil chemotaxis in vitro but not adherence or recruitment to lungs of rats with experimental pneumococcal pneumonia

Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae

Suchergebnisse filtern